Ketamine fails to outperform placebo for treating severe depression in new clinical trial

A clinical trial found that for hospitalized patients with severe depression, adding repeated ketamine infusions to standard care showed no significant benefit over a psychoactive placebo, suggesting the drug's antidepressant effects may be smaller than previously thought.